Cargando…

Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry

Patients at high risk for sudden cardiac death (SCD) may benefit from wearable cardioverter defibrillators (WCD) by avoiding immediate implantable cardioverter defibrillator (ICD) implantation. Different factors play an important role including patient selection, compliance and optimal drug treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Battrawy, Ibrahim, Kovacs, Boldizsar, Dreher, Tobias C., Klein, Norbert, Rosenkaimer, Stephanie, Röger, Susanne, Kuschyk, Jürgen, Saguner, Ardan Muammer, Kowitz, Jacqueline, Erath, Julia W., Duru, Firat, Akin, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881447/
https://www.ncbi.nlm.nih.gov/pubmed/35217697
http://dx.doi.org/10.1038/s41598-022-06007-y
_version_ 1784659467721244672
author El-Battrawy, Ibrahim
Kovacs, Boldizsar
Dreher, Tobias C.
Klein, Norbert
Rosenkaimer, Stephanie
Röger, Susanne
Kuschyk, Jürgen
Saguner, Ardan Muammer
Kowitz, Jacqueline
Erath, Julia W.
Duru, Firat
Akin, Ibrahim
author_facet El-Battrawy, Ibrahim
Kovacs, Boldizsar
Dreher, Tobias C.
Klein, Norbert
Rosenkaimer, Stephanie
Röger, Susanne
Kuschyk, Jürgen
Saguner, Ardan Muammer
Kowitz, Jacqueline
Erath, Julia W.
Duru, Firat
Akin, Ibrahim
author_sort El-Battrawy, Ibrahim
collection PubMed
description Patients at high risk for sudden cardiac death (SCD) may benefit from wearable cardioverter defibrillators (WCD) by avoiding immediate implantable cardioverter defibrillator (ICD) implantation. Different factors play an important role including patient selection, compliance and optimal drug treatment. We aimed to present real world data from 4 centers from Germany and Switzerland. Between 04/2012 and 03/2019, 708 patients were included in this registry. Patients were followed up over a mean time of 28 ± 35.5 months. Outcome data including gender differences and different etiologies of cardiomyopathy were analyzed. Out of 708 patients (81.8% males, mean age 61.0 ± 14.6), 44.6% of patients had non-ischemic cardiomyopathy, 39.8% ischemic cardiomyopathy, 7.9% myocarditis, 5.4% prior need for ICD explantation and 2.1% channelopathy. The mean wear time of WCD was 21.2 ± 4.3 h per day. In 46% of patients, left ventricular ejection fraction (LVEF) was > 35% during follow-up. The younger the patient was, the higher the LVEF and the lower the wear hours per day were. The total shock rate during follow-up was 2.7%. Whereas an appropriate WCD shock was documented in 16 patients (2.2%), 3 patients received an inappropriate ICD shock (0.5%). During follow-up, implantation of a cardiac implantable electronic device was carried out in 34.5% of patients. When comparing German patients (n = 516) to Swiss patients (n = 192), Swiss patients presented with longer wear days (70.72 ± 49.47 days versus 58.06 ± 40.45 days; p = 0.001) and a higher ICD implantation rate compared to German patients (48.4% versus 29.3%; p = 0.001), although LVEF at follow-up was similar between both groups. Young age is a negative independent predictor for the compliance in this large registry. The most common indication for WCD was non-ischemic cardiomyopathy followed by ischemic cardiomyopathy. The compliance rate was generally high with a decrease of wear hours per day at younger age. Slight differences were found between Swiss and German patients, which might be related to differences in mentality for ICD implantation.
format Online
Article
Text
id pubmed-8881447
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88814472022-03-01 Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry El-Battrawy, Ibrahim Kovacs, Boldizsar Dreher, Tobias C. Klein, Norbert Rosenkaimer, Stephanie Röger, Susanne Kuschyk, Jürgen Saguner, Ardan Muammer Kowitz, Jacqueline Erath, Julia W. Duru, Firat Akin, Ibrahim Sci Rep Article Patients at high risk for sudden cardiac death (SCD) may benefit from wearable cardioverter defibrillators (WCD) by avoiding immediate implantable cardioverter defibrillator (ICD) implantation. Different factors play an important role including patient selection, compliance and optimal drug treatment. We aimed to present real world data from 4 centers from Germany and Switzerland. Between 04/2012 and 03/2019, 708 patients were included in this registry. Patients were followed up over a mean time of 28 ± 35.5 months. Outcome data including gender differences and different etiologies of cardiomyopathy were analyzed. Out of 708 patients (81.8% males, mean age 61.0 ± 14.6), 44.6% of patients had non-ischemic cardiomyopathy, 39.8% ischemic cardiomyopathy, 7.9% myocarditis, 5.4% prior need for ICD explantation and 2.1% channelopathy. The mean wear time of WCD was 21.2 ± 4.3 h per day. In 46% of patients, left ventricular ejection fraction (LVEF) was > 35% during follow-up. The younger the patient was, the higher the LVEF and the lower the wear hours per day were. The total shock rate during follow-up was 2.7%. Whereas an appropriate WCD shock was documented in 16 patients (2.2%), 3 patients received an inappropriate ICD shock (0.5%). During follow-up, implantation of a cardiac implantable electronic device was carried out in 34.5% of patients. When comparing German patients (n = 516) to Swiss patients (n = 192), Swiss patients presented with longer wear days (70.72 ± 49.47 days versus 58.06 ± 40.45 days; p = 0.001) and a higher ICD implantation rate compared to German patients (48.4% versus 29.3%; p = 0.001), although LVEF at follow-up was similar between both groups. Young age is a negative independent predictor for the compliance in this large registry. The most common indication for WCD was non-ischemic cardiomyopathy followed by ischemic cardiomyopathy. The compliance rate was generally high with a decrease of wear hours per day at younger age. Slight differences were found between Swiss and German patients, which might be related to differences in mentality for ICD implantation. Nature Publishing Group UK 2022-02-25 /pmc/articles/PMC8881447/ /pubmed/35217697 http://dx.doi.org/10.1038/s41598-022-06007-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
El-Battrawy, Ibrahim
Kovacs, Boldizsar
Dreher, Tobias C.
Klein, Norbert
Rosenkaimer, Stephanie
Röger, Susanne
Kuschyk, Jürgen
Saguner, Ardan Muammer
Kowitz, Jacqueline
Erath, Julia W.
Duru, Firat
Akin, Ibrahim
Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
title Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
title_full Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
title_fullStr Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
title_full_unstemmed Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
title_short Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
title_sort real life experience with the wearable cardioverter-defibrillator in an international multicenter registry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881447/
https://www.ncbi.nlm.nih.gov/pubmed/35217697
http://dx.doi.org/10.1038/s41598-022-06007-y
work_keys_str_mv AT elbattrawyibrahim reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry
AT kovacsboldizsar reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry
AT drehertobiasc reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry
AT kleinnorbert reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry
AT rosenkaimerstephanie reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry
AT rogersusanne reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry
AT kuschykjurgen reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry
AT sagunerardanmuammer reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry
AT kowitzjacqueline reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry
AT erathjuliaw reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry
AT durufirat reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry
AT akinibrahim reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry